/04.jpg)
Sitemap
- ENKAM
- Platform Technology
- Product Pipeline
- Literature
-
News
- Enkam presents new results at the Society for Neur
- Commercial Partnership with STEMCELL Technologies
- ENKAM Pharmaceuticals Engages The Sage Group as Ad
- Lead Drug FGL Found To Prevent Impaired Cognition
- R&D Update, Publication & Conference Presentation
- CHDI selects ENKAM’s compounds for preclinical tes
- Presentation at BIO-Europe
- Attendance at Conferences
- Participation at Conference
- The ENKAM approach shows potential in treatment of
- Discovery of Novel Compound Classes
- Positive Preclinical Data - Traumatic Brain Injury
- Appointment of Executive Chairman
- New Promising Treatment of Alzheimer’s Disease
- EU 6FP Grants EUR9.7 million to European Research
- Glossary
- Contact ENKAM
- ENKAM Pharmaceuticals A/S
- Fruebjergvej 3, Box 58
- 2100 Copenhagen Ø
- Denmark
- Phone: +4539179715
- Fax: +4539179714